Correction: Islet-autoantibodies in gestational diabetes and risk of progression to postpartum diabetes: a systematic review and meta-analysis - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: The Role of Islet Autoantibodies in Gestational Diabetes and Their Association with Postpartum Diabetes Risk: A Systematic Review and Meta-Analysis

  • By

  • Frontiers Production Office

  • August 24, 2026

Share

Clinical Scorecard: Correction: The Role of Islet Autoantibodies in Gestational Diabetes and Their Association with Postpartum Diabetes Risk: A Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
ConditionGestational Diabetes
Key MechanismsIslet autoantibodies' role in diabetes progression
Target PopulationPregnant individuals with gestational diabetes
Care SettingEndocrinology

Key Highlights

  • Correction of figure errors in the publication
  • Manual exclusion of records based on literature searches
  • Adaptation of material from PRISMA 2020 guidelines

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Individuals with gestational diabetes

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Islet-autoantibodies in gestational diabetes and risk of progression to postpartum diabetes: a systematic review and meta-analysis

            • by Frontiers Production Office

            • August 24, 2026

            Related Content

            Beyond lipids: a precision prevention blueprint for China's residual risk

            A Mother's Search for Answers

            How one family's experience is helping improve awareness, research, and care for people living with rare diseases

            Do engagement metrics reflect educational value in short-form diabetes videos?